Fannie Mae, Freddie Mac shares tumble after conservatorship comments
Natera, Inc. (NASDAQ:NTRA) CEO and President Steven Leonard Chapman sold 1,622 shares of common stock on July 21 at a price of $139.29, totaling $225,928. The transaction comes as the company, currently valued at $19.17 billion, has shown strong revenue growth of 51.5% over the last twelve months. According to InvestingPro analysis, the stock has experienced volatile price movements recently, with shares down nearly 19% over the past six months.
On July 20, Chapman also acquired 3,386 shares of common stock upon the exercise of restricted stock units (RSUs). Investors looking for deeper insights into Natera’s financial health and growth prospects can access comprehensive analysis through InvestingPro’s detailed research report, which is part of their coverage of over 1,400 US stocks.
In other recent news, Natera reported its first-quarter 2025 earnings, surpassing analysts’ expectations with an earnings per share of -$0.50, compared to the forecasted -$0.64. The company’s revenue reached $522 million, reflecting a 37% increase from the previous year. Additionally, Natera announced that Medicare has expanded coverage for its Signatera MRD assay, now including a wider range of cancers such as colorectal, breast, and lung, among others. This expansion follows a study presented at the 2025 ASCO Annual Meeting, which emphasized the clinical utility of the Signatera Genome assay.
Analysts at Leerink Partners reiterated an Outperform rating for Natera, maintaining a price target of $220, citing recent developments in Medicare coverage. RBC Capital Markets also maintained an Outperform rating, setting a price target of $251, highlighting Natera’s strong first-quarter performance and increased revenue guidance. TD Cowen analysts raised their price target for Natera to $200, noting a 13% sales increase, driven by a 5% rise in core sales and other favorable factors. Natera’s Signatera product saw significant growth, with clinical volumes rising to approximately 17,000 in the first quarter, a 52% year-over-year increase.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.